"It's too cheap to be safe" is the most common objection we hear from first-time patients — understandably, since in most consumer purchases, price and quality move together. Healthcare pricing works differently, and it's worth understanding why.

Where the Cost Difference Actually Comes From

It isn't lower-quality materials or corner-cutting. The same FDA-approved drugs, the same implant brands, and often the same robotic surgical systems (Da Vinci, for instance) are used in Indian hospitals as in the US. The savings come from structurally lower costs elsewhere in the system: hospital real estate, staff compensation levels relative to local cost of living, and malpractice insurance premiums, which are dramatically lower in India than in the US in particular.

A Side-by-Side Example

Take a hip replacement. In the US, a large share of the ~$50,000 average bill goes toward hospital facility fees and malpractice coverage baked into the surgeon's rate — not the implant itself, which typically costs a few thousand dollars regardless of country. In India, the same implant, the same surgical technique, delivered by a similarly experienced surgeon, comes with a dramatically lower facility overhead.

  • Hip replacement — USA: $40,000–65,000 · India: $6,000–9,000
  • Cardiac bypass — USA: $120,000–200,000 · India: $6,000–10,000
  • Kidney transplant — USA: $260,000–400,000 · India: $15,000–20,000
"Ask what specific drugs, implants or systems will be used, and check they're internationally recognised brands. That's a better quality signal than price alone."

For the full comparison across every specialty we cover, see the pricing table on our homepage — every figure there is drawn from actual patient cost estimates, not marketing averages.